Clinical application of immune and targeted therapy for acute lymphoblastic leukemia
In recent years,immunotherapy and targeted therapy have attracted great concern in the field of a-cute lymphoblastic leukemia(ALL)due to its unique mechanism and weak toxicity.Many studies are committed to introducing novel immune and targeted drugs combined with or without chemotherapy for different disease sta-ges,especially for relapsed/refractory ALL patients,and have achieved significant clinical efficacy.These studies have great value for guiding the clinical medication of ALL patients.This article reviews the hotspot immunother-apy and targeted therapy for ALL.
NETL
NSTL
万方数据
